help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, N. A. C. S.
Right arrow Articles by Pignatelli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, N. A. C. S.
Right arrow Articles by Pignatelli, M.
(American Journal of Pathology. 2002;160:389-401.)
© 2002 American Society for Investigative Pathology


Review

ß-Catenin—A Linchpin in Colorectal Carcinogenesis?

Newton Alexander Chiang Shuek Wong* and Massimo Pignatelli{dagger}

From the Department of Pathology,*
University ofEdinburgh, Edinburgh, and the Department of Pathology andMicrobiology,{dagger}
Division of Histopathology,Bristol Royal Infirmary, Bristol, United Kingdom

Abstract

An important role for ß-catenin pathways in colorectal carcinogenesis was first suggested by the protein’s association with adenomatous polyposis coli (APC) protein, and by evidence of dysregulation of ß-catenin protein expression at all stages of the adenoma-carcinoma sequence. Recent studies have, however, shown that yet more components of colorectal carcinogenesis are linked to ß-catenin pathways. Pro-oncogenic factors that also release ß-catenin from the adherens complex and/or encourage translocation to the nucleus include ras, epidermal growth factor (EGF), c-erbB-2, PKC-ßII, MUC1, and PPAR-{gamma}, whereas anti-oncogenic factors that also inhibit nuclear ß-catenin signaling include transforming growth factor (TGF)-ß, retinoic acid, and vitamin D. Association of nuclear ß-catenin with the T cell factor (TCF)/lymphoid enhancer factor (LEF) family of transcription factors promotes the expression of several compounds that have important roles in the development and progression of colorectal carcinoma, namely: c-myc, cyclin D1, gastrin, cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-7, urokinase-type plasminogen activator receptor (aPAR), CD44 proteins, and P-glycoprotein. Finally, genetic aberrations of several components of the ß-catenin pathways, eg, Frizzled (Frz), AXIN, and TCF-4, may potentially contribute to colorectal carcinogenesis. In discussing the above interactions, this review demonstrates that ß-catenin represents a key molecule in the development of colorectal carcinoma.





This article has been cited by other articles:


Home page
Diabetes CareHome page
A. R. Folsom, J. S. Pankow, J. M. Peacock, S. J. Bielinski, G. Heiss, and E. Boerwinkle
Variation in TCF7L2 and Increased Risk of Colon Cancer: The Atherosclerosis Risk in Communities (ARIC) Study
Diabetes Care, May 1, 2008; 31(5): 905 - 909.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. L. Slattery, A. R. Folsom, R. Wolff, J. Herrick, B. J. Caan, and J. D. Potter
Transcription Factor 7-like 2 Polymorphism and Colon Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 978 - 982.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Bhagavathula, K. C. Nerusu, A. Hanosh, M. N. Aslam, T. B. Sundberg, A. W. Opipari Jr., K. Johnson, S. Kang, G. D. Glick, and J. Varani
7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a Benzodiazepine, Suppresses Keratinocyte Proliferation and Has Antipsoriatic Activity in the Human Skin-Severe, Combined Immunodeficient Mouse Transplant Model
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 938 - 947.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. A. Torres, J. C. Tapia, D. A. Rodriguez, A. Lladser, C. Arredondo, L. Leyton, and A. F. G. Quest
E-Cadherin Is Required for Caveolin-1-Mediated Down-Regulation of the Inhibitor of Apoptosis Protein Survivin via Reduced {beta}-Catenin-Tcf/Lef-Dependent Transcription
Mol. Cell. Biol., November 1, 2007; 27(21): 7703 - 7717.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. S. Shanmugam, H. Brenner, M. Hoffmeister, J. Chang-Claude, and B. Burwinkel
The functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk
Carcinogenesis, September 1, 2007; 28(9): 1914 - 1917.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Wei, L.-F. Lin, C.-C. Yang, Y.-C. Wang, G.-D. Chang, H. Chen, and C.-S. Chen
Thiazolidinediones Modulate the Expression of beta-Catenin and Other Cell-Cycle Regulatory Proteins by Targeting the F-Box Proteins of Skp1-Cul1-F-box Protein E3 Ubiquitin Ligase Independently of Peroxisome Proliferator-Activated Receptor {gamma}
Mol. Pharmacol., September 1, 2007; 72(3): 725 - 733.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M. J. Larriba, N. Valle, H. G Palmer, P. Ordonez-Moran, S. Alvarez-Diaz, K.-F. Becker, C. Gamallo, A. G. de Herreros, J. M. Gonzalez-Sancho, and A. Munoz
The inhibition of Wnt/{beta}-catenin signalling by 1{alpha},25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells
Endocr. Relat. Cancer, March 1, 2007; 14(1): 141 - 151.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. A.M. van de Schans, S. W.M. van den Borne, A. E. Strzelecka, B. J.A. Janssen, J. L.J. van der Velden, R. C.J. Langen, A. Wynshaw-Boris, J. F.M. Smits, and W. M. Blankesteijn
Interruption of Wnt Signaling Attenuates the Onset of Pressure Overload-Induced Cardiac Hypertrophy
Hypertension, March 1, 2007; 49(3): 473 - 480.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Freeman and R.D. Cox
Type-2 diabetes: a cocktail of genetic discovery
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R202 - R209.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Ohori, H. Yamakoshi, M. Tomizawa, M. Shibuya, Y. Kakudo, A. Takahashi, S. Takahashi, S. Kato, T. Suzuki, C. Ishioka, et al.
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer.
Mol. Cancer Ther., October 1, 2006; 5(10): 2563 - 2571.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. K. Roy, D. P. Kunte, J. L. Koetsier, J. Hart, Y. L. Kim, Y. Liu, M. Bissonnette, M. Goldberg, V. Backman, and R. K. Wali
Chemoprevention of colon carcinogenesis by polyethylene glycol: suppression of epithelial proliferation via modulation of SNAIL/{beta}-catenin signaling.
Mol. Cancer Ther., August 1, 2006; 5(8): 2060 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Koenig, C. Mueller, C. Hasel, G. Adler, and A. Menke
Collagen Type I Induces Disruption of E-Cadherin-Mediated Cell-Cell Contacts and Promotes Proliferation of Pancreatic Carcinoma Cells.
Cancer Res., May 1, 2006; 66(9): 4662 - 4671.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. A. Torres, J. C. Tapia, D. A. Rodriguez, M. Parraga, P. Lisboa, M. Montoya, L. Leyton, and A. F. G. Quest
Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin
J. Cell Sci., May 1, 2006; 119(9): 1812 - 1823.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Yan and H.-H. Tai
Glycogen Synthase Kinase-3 Phosphorylation, T-Cell Factor Signaling Activation, and Cell Morphology Change following Stimulation of Thromboxane Receptor {alpha}
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. L. Coluccia, D. Benati, H. Dekhil, A. De Filippo, C. Lan, and C. Gambacorti-Passerini
SKI-606 Decreases Growth and Motility of Colorectal Cancer Cells by Preventing pp60(c-Src)-Dependent Tyrosine Phosphorylation of {beta}-Catenin and Its Nuclear Signaling
Cancer Res., February 15, 2006; 66(4): 2279 - 2286.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S.-Y. Chen, G. Wulf, X. Z. Zhou, M. A. Rubin, K. P. Lu, and S. P. Balk
Activation of {beta}-Catenin Signaling in Prostate Cancer by Peptidyl-Prolyl Isomerase Pin1-Mediated Abrogation of the Androgen Receptor-{beta}-Catenin Interaction
Mol. Cell. Biol., February 1, 2006; 26(3): 929 - 939.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Hayashida, K. Honda, M. Idogawa, Y. Ino, M. Ono, A. Tsuchida, T. Aoki, S. Hirohashi, and T. Yamada
E-Cadherin Regulates the Association between {beta}-Catenin and Actinin-4
Cancer Res., October 1, 2005; 65(19): 8836 - 8845.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. T. Jacobs, M. R. Haussler, and M. E. Martinez
Vitamin D Activity and Colorectal Neoplasia: A Pathway Approach to Epidemiologic Studies
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2061 - 2063.
[Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Sun, M. E. Hobert, Y. Duan, A. S. Rao, T.-C. He, E. B. Chang, and J. L. Madara
Crosstalk between NF-{kappa}B and {beta}-catenin pathways in bacterial-colonized intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G129 - G137.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Gregorieff and H. Clevers
Wnt signaling in the intestinal epithelium: from endoderm to cancer
Genes & Dev., April 15, 2005; 19(8): 877 - 890.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Hughes and H. J. M. Brady
Expression of axin2 Is Regulated by the Alternative 5'-Untranslated Regions of Its mRNA
J. Biol. Chem., March 4, 2005; 280(9): 8581 - 8588.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Li, J. V. Zhang, Y.-J. Cao, J.-X. Zhou, W.-M. Liu, X.-J. Fan, and E.-K. Duan
Inhibition of the Beta-Catenin Signaling Pathway in Blastocyst and Uterus During the Window of Implantation in Mice
Biol Reprod, March 1, 2005; 72(3): 700 - 706.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. Morrison and N. Raab-Traub
Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of {beta}-Catenin Signaling
J. Virol., February 15, 2005; 79(4): 2375 - 2382.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Edlund, S. Y. Lee, S. Grimsby, S. Zhang, P. Aspenstrom, C.-H. Heldin, and M. Landstrom
Interaction between Smad7 and {beta}-Catenin: Importance for Transforming Growth Factor {beta}-Induced Apoptosis
Mol. Cell. Biol., February 15, 2005; 25(4): 1475 - 1488.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
V Johnson, E Volikos, S E Halford, E T Eftekhar Sadat, S Popat, I Talbot, K Truninger, J Martin, J Jass, R Houlston, et al.
Exon 3 {beta}-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome
Gut, February 1, 2005; 54(2): 264 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
B Perez-Ordonez, N N Huynh, K W Berean, and R C K Jordan
Expression of mismatch repair proteins, {beta} catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma
J. Clin. Pathol., October 1, 2004; 57(10): 1080 - 1083.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Ougolkov, B. Zhang, K. Yamashita, V. Bilim, M. Mai, S. Y. Fuchs, and T. Minamoto
Associations Among {beta}-TrCP, an E3 Ubiquitin Ligase Receptor, {beta}-Catenin, and NF-{kappa}B in Colorectal Cancer
J Natl Cancer Inst, August 4, 2004; 96(15): 1161 - 1170.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Morrison, M. L. Gulley, R. Pathmanathan, and N. Raab-Traub
Differential Signaling Pathways Are Activated in the Epstein-Barr Virus-Associated Malignancies Nasopharyngeal Carcinoma and Hodgkin Lymphoma
Cancer Res., August 1, 2004; 64(15): 5251 - 5260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Sun, M. E. Hobert, A. S. Rao, A. S. Neish, and J. L. Madara
Bacterial activation of {beta}-catenin signaling in human epithelia
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G220 - G227.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. B. Resnick, J. Routhier, T. Konkin, E. Sabo, and V. E. Pricolo
Epidermal Growth Factor Receptor, c-MET, {beta}-Catenin, and p53 Expression as Prognostic Indicators in Stage II Colon Cancer: A Tissue Microarray Study
Clin. Cancer Res., May 1, 2004; 10(9): 3069 - 3075.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. Pai, A. S. Tarnawski, and T. Tran
Deoxycholic Acid Activates {beta}-Catenin Signaling Pathway and Increases Colon Cell Cancer Growth and Invasiveness
Mol. Biol. Cell, May 1, 2004; 15(5): 2156 - 2163.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. E. Baldus, S. P. Monig, S. Huxel, S. Landsberg, F.-G. Hanisch, K. Engelmann, P. M. Schneider, J. Thiele, A. H. Holscher, and H. P. Dienes
MUC1 and Nuclear {beta}-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis
Clin. Cancer Res., April 15, 2004; 10(8): 2790 - 2796.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
S C C Wong, E S F Lo, A K C Chan, K C Lee, and W L Hsiao
Nuclear {beta} catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong
Mol. Pathol., December 1, 2003; 56(6): 347 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. Morrison, A. J. Klingelhutz, and N. Raab-Traub
Epstein-Barr Virus Latent Membrane Protein 2A Activates {beta}-Catenin Signaling in Epithelial Cells
J. Virol., November 15, 2003; 77(22): 12276 - 12284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sanceau, S. Truchet, and B. Bauvois
Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells
J. Biol. Chem., September 19, 2003; 278(38): 36537 - 36546.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Xie, X. Zeng, T. Waldman, and R. I. Glazer
Transformation of Mammary Epithelial Cells by 3-Phosphoinositide- dependent Protein Kinase-1 Activates {beta}-Catenin and c-Myc, and Down-Regulates Caveolin-1
Cancer Res., September 1, 2003; 63(17): 5370 - 5375.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. PAI, T. NAKAMURA, W. S. MOON, and A. S. TARNAWSKI
Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors
FASEB J, September 1, 2003; 17(12): 1640 - 1647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Xiao, C. Ghosn, C. Hinchman, C. Forbes, J. Wang, N. Snider, A. Cordrey, Y. Zhao, and R. A. S. Chandraratna
Adenomatous Polyposis Coli (APC)-independent Regulation of {beta}-Catenin Degradation via a Retinoid X Receptor-mediated Pathway
J. Biol. Chem., August 8, 2003; 278(32): 29954 - 29962.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Seike, T. Kondo, Y. Mori, A. Gemma, S. Kudoh, M. Sakamoto, T. Yamada, and S. Hirohashi
Proteomic Analysis of Intestinal Epithelial Cells Expressing Stabilized {beta}-Catenin
Cancer Res., August 1, 2003; 63(15): 4641 - 4647.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Zhang, A. Ougolkov, K. Yamashita, Y. Takahashi, M. Mai, and T. Minamoto
{beta}-Cateninand ras Oncogenes Detect Most Human Colorectal Cancer
Clin. Cancer Res., August 1, 2003; 9(8): 3073 - 3079.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. A. Grueneberg, L. Pablo, K.-Q. Hu, P. August, Z. Weng, and J. Papkoff
A Functional Screen in Human Cells Identifies UBF2 as an RNA Polymerase II Transcription Factor That Enhances the {beta}-Catenin Signaling Pathway
Mol. Cell. Biol., June 1, 2003; 23(11): 3936 - 3950.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Dihlmann, S. Klein, and M. v. K. Doeberitz
Reduction of {beta}-Catenin/T-Cell Transcription Factor Signaling by Aspirin and Indomethacin Is Caused by an Increased Stabilization of Phosphorylated {beta}-Catenin
Mol. Cancer Ther., June 1, 2003; 2(6): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yamada, Y. Mori, R. Hayashi, M. Takada, Y. Ino, Y. Naishiro, T. Kondo, and S. Hirohashi
Suppression of Intestinal Polyposis in Mdr1-deficient ApcMin/+ Mice
Cancer Res., March 1, 2003; 63(5): 895 - 901.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Gotoh, M. Obata, M. Yoshie, S. Kasai, and K. Ogawa
Cyclin D1 over-expression correlates with {beta}-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3{beta} and ERK1/2 in mouse hepatic carcinogenesis
Carcinogenesis, March 1, 2003; 24(3): 435 - 442.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Chakrabarty, V. Radjendirane, H. Appelman, and J. Varani
Extracellular Calcium and Calcium Sensing Receptor Function in Human Colon Carcinomas: Promotion of E-Cadherin Expression and Suppression of {beta}-Catenin/TCF Activation
Cancer Res., January 1, 2003; 63(1): 67 - 71.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Enam, L. Del Valle, C. Lara, D.-D. Gan, C. Ortiz-Hidalgo, J. P. Palazzo, and K. Khalili
Association of Human Polyomavirus JCV with Colon Cancer: Evidence for Interaction of Viral T-Antigen and {beta}-Catenin
Cancer Res., December 1, 2002; 62(23): 7093 - 7101.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. M. Mei, G. L. Borchert, S. P. Donald, and J. M. Phang
Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of {beta}-catenin from membrane bound E-cadherin and formation of nuclear {beta}-catenin/LEF-1 complex
Carcinogenesis, December 1, 2002; 23(12): 2119 - 2122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lepourcelet and R. A. Shivdasani
Characterization of a Novel Mammalian Groucho Isoform and Its Role in Transcriptional Regulation
J. Biol. Chem., November 27, 2002; 277(49): 47732 - 47740.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Steinert, M. Wobus, C. Boltze, A. Schutz, M. Wahlbuhl, J. Hamann, and G. Aust
Expression and Regulation of CD97 in Colorectal Carcinoma Cell Lines and Tumor Tissues
Am. J. Pathol., November 1, 2002; 161(5): 1657 - 1667.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Levy, C. Neuveut, C.-A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A.-F. Petit-Bertron, D. Mathieu, et al.
Transcriptional Activation of Interleukin-8 by beta -Catenin-Tcf4
J. Biol. Chem., October 25, 2002; 277(44): 42386 - 42393.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Takahashi, M. Fujita, Y. Furukawa, R. Hamamoto, T. Shimokawa, N. Miwa, M. Ogawa, and Y. Nakamura
Isolation of a Novel Human Gene, APCDD1, as a Direct Target of the {beta}-Catenin/T-Cell Factor 4 Complex with Probable Involvement in Colorectal Carcinogenesis
Cancer Res., October 15, 2002; 62(20): 5651 - 5656.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. D. Girnun, W. M. Smith, S. Drori, P. Sarraf, E. Mueller, C. Eng, P. Nambiar, D. W. Rosenberg, R. T. Bronson, W. Edelmann, et al.
APC-dependent suppression of colon carcinogenesis by PPARgamma
PNAS, October 15, 2002; 99(21): 13771 - 13776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. G. Munshi, S. Ghosh, S. Mukhopadhyay, Y. I. Wu, R. Sen, K. J. Green, and M. S. Stack
Proteinase Suppression by E-cadherin-mediated Cell-Cell Attachment in Premalignant Oral Keratinocytes
J. Biol. Chem., October 4, 2002; 277(41): 38159 - 38167.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.